Neoadjuvant FOLFIRINOX versus Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy for Resectable and Borderline Resectable Pancreatic Cancer: Update on the Nationwide Multicenter PREOPANC-2 Randomized Trial. (2021) - Janssen, Q.P.; Besselink, M.G.; Homs, M.Y.V.; van Tienhoven, G.; Wilmink, J.W.; Groot Koerkamp, B.; ,